Mortality in diabetic patients undergoing non-cardiac surgery: A 7-year follow-up study

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 6, 2009, Pages 749-758

  Krolikowska, M ^a   Kataja, M ^b   Ppyhia R ^a   Drzewoski, J ^c   Hynynen, M ^a  

^a JORVI HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINARY TRACT INFECTION; WOUND INFECTION;

AGE FACTORS; AGED; BODY MASS INDEX; CAUSE OF DEATH; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS;

EID: 67149131681     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.01963.x     Document Type: Article

References (50)

1. Järveläinen H, Lahtela J. Insuliinihoito tänään. Vaihtoehtoina tulevaisuudessa myös inhaloivat insuliinit (Finnish). Suom Lääkäril 2007 62 : 3869 76.
2. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlsson BW, Karlsson T, Albertsson P, Westberg S. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary bypass grafting. Diabetes Care 1996 19 : 698 703. (Pubitemid 126752470)
3. Herlitz J, Wognsen GB, Karlson BW, Sjöland H, Karlsson T, Caidahl K, Hartford M, Haglid M. Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus. Coronary Art Dis 2000 11 : 339 46.
4. Hjortrup A, Rasmussen BF, Kehlet H. Morbidity in diabetic and non-diabetic patients after major vascular surgery. Br Med J Clin Res Ed 1983 287 : 1107 8.
5. Lawrie GM, Morris GC Jr., Glaeser DH. Influence of diabetes mellitus on the result of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery. J Am Med Assoc 1986 256 : 2867 71.
6. Stewart RD, Lahley SJ, Levitsky S, Sanchez C, Campos CT. Clinical and economic impact of diabetes following coronary artery bypass. J Surg Res 1998 76 : 124 30.
7. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002 74 : 712 9.
8. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, Guyton RA. Influence of diabetes mellitus on early and late outcome after coronary bypass grafting. Ann Thorac Surg 1999 67 : 1045 52.
9. Zerr KJ, Funnary AP, Grunkemeier GI, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetes after open heart operations. Ann Thorac Surg 1997 63 : 356 61.
10. Clement S, Braithwaite S, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004 27 : 553 91.
11. Hamdan AD, Saltzberg SS, Sheahan M, Froelich J, Akbari CM, Campbell DR, LoGerfo FW, Pomposelli FB Jr. Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: results of 6565 major vascular operations. Arch Surg 2002 137 : 417 21.
12. Guckelberg O, Thelen A, Bencker C, Schoebel C. Diabetes mellitus in no independent risk factor for perioperative mortality following hepatic resection. Exp Clin Endocrinol Diabetes 2006 114 : 257 61.
13. Axelrod DA, Al E. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. J Vasc Surg 2002 35 : 894 901. (Pubitemid 44718555)
14. Rockman CB, Saltzberg SS, Maldano TS, Adelman MA, Cayne NS, Lamparello PJ, Riles TS. The safety of carotid endarterectomy in diabetic patients: clinical predictor of adverse outcome. J Vasc Surg 2005 42 : 873 83.
15. Aziz I, Lewis R, Baker JD, De Virgilio C. Cardiac morbidity and mortality following carotid endarterectomy: the importance of diabetes and multiple Eagle risk factors. Ann Vasc Surg 2001 15 : 243 46.
16. Juul AB, Wetterslev J, Kofoed-Enevoldsen A. Long-term postoperative mortality in diabetic patients undergoing major non-cardiac surgery. Eur J Anaesthesiol 2004 21 : 523 9.
17. Mangano DT, Layug AL, Wallace A, Tateo I. Effect o atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Peri-operative Ischemia Research Group. N Engl J Med 1996 335 : 1713 20.
18. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and micro-vascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000 321 : 405 12.
19. Owens W, Felts J, Spitznagel E Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978 49 : 239 43.
20. Ranta S, Hynynen M, Tammisto T. A survey of the ASA physical status classification: significant variation in allocation among Finnish anaesthesiologists. Acta Anaesthesiol Scand 1997 41 : 629 32.
21. Hakulinen T. On long-term relative survival rates. J Chron Dis 1977 30 : 431 43.
22. Hakama M, Hakulinen T. Estimating the expectation of the life in cancer survival studies with incomplete follow-up information. J Chron Dis 1977 30 : 585 97.
23. Morricone L, Ranucci M, Denti S, Cazzaninga A, Isgro G, Enrini R, Caviezel F. Diabetes and complications after cardiac surgery: comparison with a non-diabetic population. Acta Diabetol 1999 36 : 77 84.
24. Risum O, Abdelnoor M, Svennevig JI, Svennevig JL, Levorstad K, Gullestad L, Bjørnerheim R, Simonsen S, Nitter-Hauge S. Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thor Cardiovasc Surg 1996 30 : 71 5.
25. Yeager RA, Moneta GI, Mcgonell DB, Nebwelt EA, Taylor LM, Porter JM. Analysis of risk factors for myocardial infarction following carotid endarterectomy. Arch Surg 1989 128 : 1142 45.
26. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylönen K, Lepäntalo M. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularisation for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 2007 31 : 217 25 discussion 26-7.
27. O'Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, Lowery A, Sultan S. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and a predictor of adverse outcome? Eur J Vasc Endovasc Surg 2006 32 : 188 97.
28. Awad S, Karkos CD, Serrachino-Inglott F, Coper NJ, Butterfield JS, Ashleigh R, Nasim A. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischemia. Eur J Vasc Surg 2006 32 : 51 9.
29. Attinger CE, Ducic I, Hess CL, Basil A, Abbruzzesse M, Cooper P. Outcome of skin graft versus flap surgery in the salvage of the exposed Achilles tendom in diabetics versus nondiabetics. Plastic Reconstruct Surg 2006 117 : 2460 7.
30. Jamal MK, DeMaria EJ, Johnson JM, Carmody BJ, Wolfe LG, Kellum JM, Meador JG. Impact of major co-morbidities on mortality and complications after gastric bypass. Surg Obes Relat Dis 2005 1 : 511 6.
31. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patient after cardiac surgical procedures. Ann Thorac Surg 1999 67 : 352 60.
32. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004 2 : 21 33.
33. Van Den Berg G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001 345 : 1359 67.
34. Van Den Berg G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical-surgical intensive care units: benefit versus harm. Diabetes 2006 55 : 3151 9.
35. Van den Berg G. Insulin therapy in the intensive care unit should be targed to maintain blood glucose between 4.4 mmol-l and 6.1 mmol-l. Diabetologia 2008 51 : 911 5.
36. Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Denkelgrum M, Bax JJ, Klein J, Poldermans D. Increased preoperative glucose levels are associated with peri-operative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007 156 : 137 42.
37. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990 323 : 1781 8.
38. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau FJ, Krupski WC. Perioperative myocardial ischemia in patients undergoing noncardiac surgery. Incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 1991 17 : 843 50.
39. Fowkes FG, Lunn JN, Farrow SC, Robertson IB, Samuel P. Epidemiology in anaesthesia. III: mortality risk in patients with coexisting physical disease. Br J Anaesth 1982 54 : 819 25.
40. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and in hospital mortality for 108, 927 patients in the Acute Decompensated Heart Failure National Registery. Am Heart J 2007 153 : 74 81. (Pubitemid 44880872)
41. Sagar U, Ahmed M, Adams S, Whellan D. Does body mass index really matter in the management of heart failure?: a review of the literature. Cardiol Rev 2008 16 : 124 8.
42. Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. Br Med J 2006 332 : 1115 24.
43. Lindenauer PK, Pekow P, Wang K. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005 353 : 349 61.
44. Juul AB, Wetterslev J, Gluud C, Group DT. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicenter trial. Br Med J 2006 332 : 1482 8.
45. Powell JT, Pobble TI. Perioperative beta-blockade with metopropolol did not seem to reduce 30-day cardiovascular events. J Vasc Surg 2005 41 : 602 9.
46. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P. Effect of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008 371 : 1839 47.
47. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli F. Perioperative beta-blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008 372 : 1962 76.
48. Boersma E, Poldermans D. Beta blockers in non-cardiac surgery: hemodynamic data needed. Lancet 2008 372 : 1930 2.
49. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technology Assessment 2003 7 : 1 108.
50. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 358 : 2545 59.